allergic asthma (Moore WC, et al AJRCCM, 2010). We hypothesized that common and potentially deleterious rare variation in this pathway would be associated with severe asthma based on SARP cluster designation. Methods: To evaluate common variants (minor allele frequency or MAF .5%), 419 SARP non-Hispanic white participants with a cluster assignment were genotyped for 182 single nucleotide polymorphisms (SNPs) in Th2 pathway genes using whole-genome SNP data. Individual SNPs and a cumulative model of significant SNPs were evaluated using contingency tables with a chisquare test for trend and ordinal regression models adjusted for age, sex, and principal components. Rare (MAF ,5%) amino acid changes and splice site alterations in this pathway were tested for association with asthma severity outcomes in 20 SARP subjects with whole exome sequence data. Results: Individual Th2 pathway variants were associated with overall SARP cluster assignment, and allergic clusters of increasing severity (1, 2, and 4), including GATA3 polymorphism rs1244186 (P ¼ 0.005). In an 18-SNP additive model, an increasing number of Th2 pathway risk genotypes were highly associated with severe allergic asthma (P ¼ 3.9 · 10 26 ). For example, in cluster 4, the percentage of subjects with at least 9 risk genotypes was 83% compared to 35% in cluster 1. Additionally, there was evidence that subjects with rare variants in this pathway were more likely to report allergy symptoms (P ¼ 0.006), especially in the fall (P ¼ 0.003), compared to subjects with no rare variants. Conclusions: Common Th2 pathway variants predict an increased likelihood of severe allergic asthma and rare variants were associated with increased seasonal allergy symptoms.
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Role of Myeloid Derived Suppressor Cells in Asthma
Nanomedicine Research Center and Divisions of Translational Medicine, Allergy and Immunology, Departments of Internal Medicine and Molecular Medicine, University of South Florida and James V Haley Veterans' Hospital, Tampa, FL. Background: We know that a heterogeneous group of myeloid cells termed myeloid derived suppressor cells (MDSC) accumulate in almost all pathological conditions, which elicit an inflammatory signal. The exact role played by these cells in asthma is not known. In this study we investigated the function and role of these cells in asthma. Methods: Accumulation of MDSC and other subsets of myeloid cells were analyzed from peripheral blood mononuclear cells from patients with nonsevere asthma (FEV 1 ) .60) and severe asthma (FEV 1 ,60) by multicolorflowcytometry and compared to healthy controls. Allergic mouse models were used to determine the role of microRNA-142 (miR-142) in regulation and expansion of MDSC. Results: There is a significant increase in the proportion of MDSC in severe versus non-severe asthmatics and controls, corresponding to a decrease in myeloid dendritic cells. Allergic mice had significant increased levels of MDSC expansion which were associated with increased levels of IL-6 and downregulation of miR-142. miR-142 overexpression induced MDSC differentiation.
Conclusions: An accumulation of MDSC is associated with severe asthma in humans and mice. In an allergic mouse model, IL-6 levels increase. miR-142 may play an important role in regulation and differentiation of MDSC, leading to altered immunity. Methods: In the present study, we used miRNA array profiling in a mouse model of ovalbumin-induced asthma to identify differentially regulated miRNAs and characterized miR-150 in terms of cellular and humoral involvement and analysis of lung inflammation markers. Results: We found that miR-150 was downregulated in CD4 T lymphocytes during asthmatic inflammation and Th1 and Th2 induction. Over-expression of miR-150 delivered by chitosan nanoparticles inhibited lung inflammation and decreased Th1 and Th2 cytokine levels. miR-150 suppressed Akt3, Cbl1 and Elk1 oncogenes, which are involved in inflammation and cytokine production. Transgenic mice overexpressing miR-150 are resistant to asthma induction, demonstrated by reduced AHR and cytokine inflammation production. Conclusions: These results suggest that deregulation of miRNAs may be involved in the pathogenesis of asthma and miR-150 may suppress inflammation in asthma by inhibiting cytokine production by downregulating critical genes such as Akt, Elk1 and Cbl1. miR-150 may be an attractive candidate for asthma gene therapy.
Serine Protease Inhibitor Attenuates Ova Induced Inflammation in Mouse Model of Allergic Airway Disease
Sanjay Sawc, MSc, Sagar Kalec, MSc, Bhanu Pratap Singh, PhD, and Naveen Arora, PhD. Allergy and Immunology, Institute of Genomics and Integrative Biology, Delhi, India. Background: Serine proteases promote inflammation and tissue remodeling by activating proteinase-activated receptors, urokinase, metalloproteinases and angiotensin. In the present study, AEBSF (4-(2-Aminoethyl) benzenesulfonyl fluoride) a serine protease inhibitor, was evaluated for prophylactic and therapeutic treatment in mouse model of airway allergy. Methods: BALB/c mice were sensitized by i.p route on 0 and 14 day and challenged with OVA (25, 26 and 27 day) by i.n. route. Mice were treated i.n. with AEBSF, 1 hour before/after challenge and sacrificed on day 29 to collect BALF, blood and lungs. OVA specific immunoglobulins were measured in serum. Proteolytic activity, total cell/eosinophil count, eosinophil peroxidase activity (EPO), IL-4, IL-5, IL-10, cysteinyl leukotrienes and 8-isoprostane (oxidative stress marker) were determined in BALF. Haematoxylin and eosin stained lung sections were examined for cellular infiltration and airway inflammation. Results: Mice exposed to OVA and treated with PBS showed significantly high levels of IgE, IgG1 and IgG2a as compared to sham mice. Both prophylactic and symptomatic AEBSF treatment reduced serum IgE and IgG1 significantly (P # 0.05) than control, however there was little increment in IgG2a level. AEBSF could effectively reduce the proteolytic activity inDepartment of Pharmacology, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel. Background: Human atherosclerotic lesions contain mast cells and oxidatively modified low-density lipoprotein particles (oxLDL). Scavenger receptors are cell surface receptors that bind and internalize oxLDL, and they play an important role in macrophage foam cell development, a key event in the initiation and development of atherosclerotic lesions. The purpose of the study was to analyze expression of the most common scavenger receptors in mast cells, and determine whether oxLDL particles can induce them to secrete pro-inflammatory cytokines that are potentially capable of inducing and amplifying atherogenic processes. Methods: Mast cells were differentiated from human cord blood-derived CD341 progenitor cells in vitro (CBMC), and their expression of scavenger receptors was analyzed by conventional RT-PCR, flow cytometry and Western blot techniques. Fluorescently-labeled oxLDL was used to investigate LDL internalization by mast cells. Secretion of pro-inflammatory cytokines into the incubation medium and degranulation of the mast cells in response to oxLDL were assayed by ELISA and a colorimetric-enzymatic test for betahexosaminidase, respectively. Results: CBMC expressed mRNA and protein for LOX-1, SR-AI and CD68, but not for CD36, and the expression of LOX-1 and SR-AI was upregulated by incubation of the cells with oxLDL. CBMC internalized oxLDL more efficiently than native LDL, while simultaneous neutralization of CD68, SR-AI and LOX-1 with monoclonal antibodies resulted in reduced oxLDL uptake. Moreover, in response to oxLDL, CBMC showed increased release of b-hexosaminidase, and a dose-dependent secretion of the pro-inflammatory cytokines IL-8 and MCP-1. Conclusion: Our results reveal that cultured human mast cells express scavenger receptors that are upregulated by oxLDL. In atherosclerotic lesions, oxLDL may activate MC to secrete pro-inflammatory cytokines, and so they cause mast cells to act as a cellular link between oxLDL and the inflammatory response in atherosclerosis. ImmunologyAllergology, University of Medicine and Pharmacy, Cluj-Napoca, Romania; 3 Allergology, Almedo Clinic, Cluj Napoca, Romania. Background: The prevalence of pollen allergy is estimated around 40% in general population. Ragweed (ambrosia artemisiifolia) pollen represents a major source of allergen but was rare in Romania. The aim is to evaluate the symptoms and associated factors in patients with allergic rhinitis to ragweed pollen in the northwest region of Romania. Methods: 74 patients (pts) (mean age 27.97 6 13.85 years) with allergic rhinitis to ragweed pollen were included in the study. The patients were clinically evaluated regarding the severity of the symptoms on a scale from 0 to 3 and their duration. A total score over 6 indicates a moderate/severe form of rhinitis. We evaluated the association with other allergic manifestations (asthma and urticaria). All the patients had skin prick tests to inhalant allergens. The obtained data were statistically analyzed using Anova, Chisquare and Fischer tests, with a significance of P , 0.05. Results: 50.94% of the pts were female. 58.1% of them presented mild allergic rhinitis, while 41.9% moderate severe forms. 27% of the pts were monosensitised to ragweed pollen and 73% of the pts were polisensitised. The patients monosensitised to ragweed had moderate/severe forms of rhinitis (14 vs 86%, P ¼ 0.004) compared with polisensitised group. The symptoms score was higher in pts with monosensitisation compared with polisensitisation pts (7.05 vs 5.28, P ¼ 0.02). In monosensitized group the ocular szmptoms were more frequently present (65 vs 18%, P ¼ 0.02) and were more severe (0.65 vs 0.33, P ¼ 0.01). The number of pts with association of allergic rhinitis and asthma was higher in the polisensitised group compared to the monosensitised one (44.4 vs 11.11%, P ¼ 0.029). The interval between the onset of the symptoms and diagnosis of rhinitis is higher in polisensitised pts and significantly increased in pts with asthma. There is no correlation between environment (rural-urban), age, sex, family and personal allergic history and the type of sensitisation and severity of the symptoms. Conclusions: Ragweed produces intense allergogen pollen and determines severe forms of allergic rhinitis and also the presence of ocular symptoms. Polisensitisation increases the risk of associated asthma and also increases the interval betweeen the onset of the symptoms and diagnosis. Little is yet known about the sensitization and allergy rates in Bavaria. Methods: In 2008 to 2010 patients from a Bavarian university allergy unit were enrolled into the study. The patient's history was recorded by a standardised questionnaire concerning allergies. Sensitization rates were measured by skin prick test (SPT) for seasonal aeroallergens including ragweed. Patients sensitized to ragweed were further characterized by measuring specific serum immunoglobulin E (IgE) for ragweed specific allergens (by ImmunoCAP and ELISA). To determine the clinical relevance challenge tests (nasal/conjunctival) with ragweed were performed. Results: 1022 patients were enrolled in the study (665 female, 357 male). 289 patients were sensitized to ragweed (SPT positive). In ragweed sensitized patients the sensitization rate to mugwort was 61.8% whilst in patients not sensitized to ragweed it was 7.4%. The sensitization to birch was 78.1% resp. 36.4%. In 120 ragweed sensitized patients challenge tests with ragweed extract were performed (nasal n ¼ 110; conjunctival n ¼ 60) with positive results in 29 (26%) resp. 12 (20%) patients. In 232 ragweed sensitized patients specific IgE to nArt v 1 was observed significantly more frequently than to nAmb a 1.
ALLERGIC RHINITIS
Conclusions:
The results of this 3-year study show that in a Bavarian allergy unit sensitization to ragweed is frequent. Often ragweed-sensitized patients have sensitivities to multiple seasonal aeroallergens. There is a coexistence of ragweed and mugwort specific allergens. One fourth of the challenged
